Urinary Catheters Market Is Estimated To Witness High Growth Owing To Infection Prevention Measures
 |
| Urinary Catheters Market |
A)
Market Overview:
The global Urinary Catheters Market is estimated to be valued at US$ 5,293.6 Million In 2022 and is
expected to exhibit a CAGR of 5.6%
over the forecast period 2022-2030. Urinary catheters are medical devices that
are used to manage urinary incontinence or urinary retention. They provide a
variety of advantages such as continuous urine drainage, prevention of bladder
damage, and improved patient comfort. The increasing prevalence of urinary disorders,
growing geriatric population, and advancements in catheterization techniques
are driving the demand for urinary catheters. These devices are essential for
patients who are unable to empty their bladders naturally, providing them with
a better quality of life.
B) Market Key Trends:
One key trend in the Urinary
Catheters Market is the increasing adoption of advanced catheterization
techniques. Traditional catheterization methods often lead to complications
such as infection, blockage, and tissue damage. To overcome these issues,
healthcare providers are adopting innovative techniques such as hydrophilic
catheterization, intermittent catheterization, and antimicrobial-coated
catheters. These advanced catheterization techniques improve patient comfort, reduce
the risk of urinary tract infections, and enhance the overall effectiveness of
urinary catheterization. Furthermore, technological advancements in catheter
materials and designs are also contributing to the market growth. The
development of minimally invasive and self-inserted catheters is gaining
traction, providing convenience and ease of use for patients. Overall, the
increasing adoption of advanced catheterization techniques is driving the
demand for urinary catheters in the market.
Segment Analysis:
The urinary catheters market can be segmented based on product type, end-user,
and region. In terms of product type, the market can be divided into Foley
catheters, intermittent catheters, external catheters, and others. Among these,
the Foley catheters segment is expected to dominate the market during the
forecast period. Foley catheters are widely used for long-term catheterization
and are preferred by healthcare professionals due to their convenience and
effectiveness. Additionally, there is a growing prevalence of chronic diseases
such as urinary incontinence and urinary retention, which further drives the
demand for Foley catheters.
In terms of end-user, the urinary catheters market can be categorized into
hospitals, ambulatory surgical centers, and others. The hospital segment is
expected to dominate the market as hospitals are the primary healthcare
facilities where catheterization procedures are performed. Moreover, the rising
number of patient admissions in hospitals and the availability of advanced
healthcare infrastructure contribute to the dominance of this segment.
Key Takeaways:
The global urinary catheters market is expected to witness high growth,
exhibiting a CAGR of 5.6% over the forecast period. This growth can be
attributed to several factors. Firstly, there is a growing prevalence of
urinary retention, urinary incontinence, and other urinary disorders, which
increases the demand for urinary catheters. Additionally, the geriatric
population is prone to such urological conditions, and with the increasing
elderly population worldwide, the market is expected to expand significantly.
Regionally, North America is projected to be the fastest-growing and dominating
region in the urinary catheters market. This can be attributed to the presence
of key market players, advanced healthcare infrastructure, and a rising
geriatric population. The favorable reimbursement policies and increasing
healthcare expenditure in the region also contribute to its dominance.
Some of the key players operating in the urinary catheters market are B. Braun
SE, Coloplast Group, BD, Cathetrix, Hollister Incorporated, Boston Scientific
Corporation, Medtronic, Bactiguard AB, Amecath, Urocare Products, Inc.,
Rocamed, Cook, Ribbel International Limited, Otsuka Pharmaceutical Factory,
Inc., Sonoma Pharmaceuticals, Inc., Affera, Inc., HR Pharmaceuticals, Inc.,
Potrero Medical, Ingenion Medical, and The Flume Catheter Company Ltd. These
players focus on strategies such as mergers and acquisitions, product launches,
and collaborations to strengthen their market position and expand their product
portfolios.
Comments
Post a Comment